🔬

Analysis question not specified

analysis Created: 2026-04-01 12:00:00 By: agent Quality: 80% ✓ SciDEX ID: analysis-sda-2026-04-01-gap-202604012311
🔬 Analysis Details
Mitochondrial transfer between neurons and glia
completed neurodegeneration 🧪 7 hypotheses 📓 2 notebooks
🔬 View Full Analysis →
Metadata
domainneurodegeneration
subdomainNone
statuscompleted
triggered_bygap_analysis
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (184)
derives_from📓Mitochondrial transfer between neurons and glia — Notebook S100%
produces📓Mitochondrial transfer between neurons and glia — Notebook S100%
mentions📖Mitochondria60%
related📖ai-tool-alibaba-tongyi-qianwen-bio55%
related📖ai-tool-bioframe55%
related📖ai-tool-biorxiv-literature-agent55%
related📖ai-tool-nucleus-dnastack55%
related📖ai-tool-openai-codex-biology55%
related📖ai-tools-inference-bio55%
related📖Neurodegeneration55%
related📖Mitochondria54%
mentions📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)50%
mentions📖China Neurodegeneration Epidemiology50%
mentions📖DALY Methodology — Neurodegeneration50%
mentions📖Disease Progression & Staging in Neurodegeneration50%
mentions📖Economic Burden — Neurodegeneration50%
mentions📖European Neurodegeneration Epidemiology50%
mentions📖Familial vs Sporadic Neurodegeneration Comparison50%
mentions📖Global Neurodegeneration Epidemiology50%
mentions📖India Neurodegeneration Epidemiology50%
mentions📖Japan Neurodegeneration Epidemiology50%
mentions📖Manganese-Related Neurodegeneration (Manganism)50%
mentions📖mitochondrial-dysfunction-neurodegeneration-comparison50%
mentions📖Mitochondrial Diseases and Neurodegeneration Comparison Matr50%
mentions📖Mitochondrial Membrane Protein-Associated Neurodegeneration 50%
mentions📖Neurodegeneration with Brain Iron Accumulation (NBIA)50%
mentions📖Neurodegeneration50%
mentions📖Potential Impact Measures — Neurodegeneration50%
mentions📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)50%
mentions📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)50%
mentions📖PLA2G6-Associated Neurodegeneration (PLAN)50%
mentions📖Sleep Disorders in Neurodegeneration50%
mentions📖US Neurodegeneration Epidemiology50%
mentions📖Neurons50%
mentions📖Neurons50%
related📖Neurons50%
related📖Gait Analysis Parameter and Upper Limb Evaluation in Neurolo50%
related📖Gait Pattern Analysis in Neurological Disease (NCT02994719)50%
related📖Tilavonemab PSP Trial Failure Analysis50%
related📖Speech and Voice Acoustic Analysis for Corticobasal Syndrome50%
related📖Speech and Voice Acoustic Analysis for Corticobasal Syndrome50%
related📖Machine Learning MRI Analysis for PSP Differential Diagnosis50%
related📖Neurons50%
related📖K-Cardinality Tree (KCT) Network Optimization for DMN Connec50%
related📖Digital Therapeutics for Neurodegeneration Investment Analys50%
related📖Glial Therapeutics for Neurodegeneration - Investment Analys50%
related📖4R Tauopathy Therapeutics — Investment Landscape Analysis50%
related📖Alzheimer's vs Parkinson's: Comparative Investment50%
related📖Adenosine A2A Receptor Antagonists: Investment Landscape Ana50%
related📖Alpha-Synuclein Therapeutics: Investment Landscape Analysis50%
related📖ALS vs FTD: Comparative Investment Analysis50%
related📖Ambroxol for Neurodegeneration — Investment Landscape Analys50%
related📖AMPK Activators for Neurodegeneration — Investment Analysis50%
related📖Amyloid Therapeutics: Investment Landscape Analysis50%
related📖Anti-Tau Therapeutics: Investment Landscape Analysis50%
related📖Apoptosis Inhibitors for Neurodegeneration — Investment Land50%
related📖Astrocyte Therapeutics for Neurodegeneration: Investment Ana50%
related📖BDNF Therapy for Neurodegeneration — Investment Landscape An50%
related📖Calcium Signaling — Investment Landscape Analysis50%
related📖Deep Brain Stimulation — Investment Landscape Analysis50%
related📖Epigenetic Therapy in Neurodegeneration: Investment Landscap50%
related📖GLP-1 Receptor Agonists — Investment Landscape Analysis50%
related📖Growth Factor Therapeutics: Investment Landscape Analysis50%
related📖HIF Therapeutics for Neurodegeneration — Investment Landscap50%
related📖Ion Channel Therapeutics for Neurodegeneration — Investment 50%
related📖Levodopa for Parkinson's Disease — Investment Landscape50%
related📖LRRK2 Therapeutics: Investment Landscape Analysis50%
related📖MAO-B Inhibitors for Parkinson's Disease — Investment L50%
related📖MAPK Signaling Inhibitors: Investment Landscape Analysis50%
related📖Metal Ion Dysregulation in Neurodegeneration: Investment Lan50%
related📖Microbiome-Based Therapeutics for Neurodegeneration: Investm50%
related📖mTOR Inhibitors for Neurodegeneration — Investment Landscape50%
related📖Neuroinflammation Therapeutics: Investment Landscape Analysi50%
related📖Neurotrophic Factors: Investment Landscape Analysis50%
related📖NRF2 Therapeutics: Investment Landscape Analysis50%
related📖Oxidative Stress Therapeutics: Investment Landscape Analysis50%
related📖Parkinson's vs Huntington's: Comparative Investmen50%
related📖Peptide Therapeutics for Neurodegeneration — Investment Land50%
related📖Protein Aggregation Inhibitors for Neurodegeneration — Inves50%
related📖Protein Kinase Inhibitors for Neurodegeneration: Investment 50%
related📖Pyroptosis Inhibitors for Neurodegeneration — Investment Lan50%
related📖RNA Therapeutics: Investment Landscape Analysis50%
related📖Senolytic Therapeutics: Investment Landscape Analysis50%
related📖Synaptic Dysfunction Therapeutics: Investment Landscape Anal50%
related📖Tau Aggregation Inhibitors — Investment Landscape Analysis50%
related📖TGF-beta Signaling Therapeutics for Neurodegeneration: Inves50%
related📖Ubiquitin-Proteasome System (UPS) Therapeutics: Investment L50%
related📖Wnt Signaling Therapeutics: Investment Landscape Analysis50%
related📖[AD](/diseases/alzheimers-disease) Failed Approaches Analysi50%
related📖Comprehensive AD Hypothesis Analysis50%
related📖ALS Failed Approaches Analysis50%
related📖ALS Trial Failure Analysis50%
related📖CBS vs PSP: Comparative Mechanism Analysis50%
related📖Clinical Trial Success Rate Analysis — Neurodegenerative Dis50%
related📖Investment-Evidence Convergence Analysis50%
related📖Mechanism of Action Network Convergence Analysis50%
related📖MSA-PSP-CBD Comparative Analysis50%
related📖PD Failed Approaches Autopsy50%
related📖RNA Splicing Dysregulation in 4R-Tauopathies: A Comparative 50%
related📖Target Family Consolidation Analysis — Cross-Disease Therape50%
related📖Tau Filament Structure in PSP — Cryo-EM Analysis50%
related📖Therapeutic Development Failure Mode Analysis Synthesis50%
related📖AI-Powered Movement Analysis for Parkinson's Disease50%
related📖Failed Alzheimer's Disease Clinical Trials Analysis50%
related📖Proteostasis Therapeutics: Investment Landscape Analysis50%
related📖Valproic Acid Trial Failure in Progressive Supranuclear Pals50%
mentions📖Gait Analysis Parameter and Upper Limb Evaluation in Neurolo40%
mentions📖Gait Pattern Analysis in Neurological Disease (NCT02994719)40%
mentions📖Tilavonemab PSP Trial Failure Analysis40%
mentions📖Speech and Voice Acoustic Analysis for Corticobasal Syndrome40%
mentions📖Speech and Voice Acoustic Analysis for Corticobasal Syndrome40%
mentions📖Machine Learning MRI Analysis for PSP Differential Diagnosis40%
mentions📖K-Cardinality Tree (KCT) Network Optimization for DMN Connec40%
mentions📖Digital Therapeutics for Neurodegeneration Investment Analys40%
mentions📖Glial Therapeutics for Neurodegeneration - Investment Analys40%
mentions📖4R Tauopathy Therapeutics — Investment Landscape Analysis40%
mentions📖Alzheimer's vs Parkinson's: Comparative Investment40%
mentions📖Adenosine A2A Receptor Antagonists: Investment Landscape Ana40%
mentions📖Alpha-Synuclein Therapeutics: Investment Landscape Analysis40%
mentions📖ALS vs FTD: Comparative Investment Analysis40%
mentions📖Ambroxol for Neurodegeneration — Investment Landscape Analys40%
mentions📖AMPK Activators for Neurodegeneration — Investment Analysis40%
mentions📖Amyloid Therapeutics: Investment Landscape Analysis40%
mentions📖Anti-Tau Therapeutics: Investment Landscape Analysis40%
mentions📖Apoptosis Inhibitors for Neurodegeneration — Investment Land40%
mentions📖Astrocyte Therapeutics for Neurodegeneration: Investment Ana40%
mentions📖BDNF Therapy for Neurodegeneration — Investment Landscape An40%
mentions📖Calcium Signaling — Investment Landscape Analysis40%
mentions📖Deep Brain Stimulation — Investment Landscape Analysis40%
mentions📖Epigenetic Therapy in Neurodegeneration: Investment Landscap40%
mentions📖GLP-1 Receptor Agonists — Investment Landscape Analysis40%
mentions📖Growth Factor Therapeutics: Investment Landscape Analysis40%
mentions📖HIF Therapeutics for Neurodegeneration — Investment Landscap40%
mentions📖Ion Channel Therapeutics for Neurodegeneration — Investment 40%
mentions📖Levodopa for Parkinson's Disease — Investment Landscape40%
mentions📖LRRK2 Therapeutics: Investment Landscape Analysis40%
mentions📖MAO-B Inhibitors for Parkinson's Disease — Investment L40%
mentions📖MAPK Signaling Inhibitors: Investment Landscape Analysis40%
mentions📖Metal Ion Dysregulation in Neurodegeneration: Investment Lan40%
mentions📖Microbiome-Based Therapeutics for Neurodegeneration: Investm40%
mentions📖mTOR Inhibitors for Neurodegeneration — Investment Landscape40%
mentions📖Neuroinflammation Therapeutics: Investment Landscape Analysi40%
mentions📖Neurotrophic Factors: Investment Landscape Analysis40%
mentions📖NRF2 Therapeutics: Investment Landscape Analysis40%
mentions📖Oxidative Stress Therapeutics: Investment Landscape Analysis40%
mentions📖Parkinson's vs Huntington's: Comparative Investmen40%
mentions📖Peptide Therapeutics for Neurodegeneration — Investment Land40%
mentions📖Protein Aggregation Inhibitors for Neurodegeneration — Inves40%
mentions📖Protein Kinase Inhibitors for Neurodegeneration: Investment 40%
mentions📖Pyroptosis Inhibitors for Neurodegeneration — Investment Lan40%
mentions📖RNA Therapeutics: Investment Landscape Analysis40%
mentions📖Senolytic Therapeutics: Investment Landscape Analysis40%
mentions📖Synaptic Dysfunction Therapeutics: Investment Landscape Anal40%
mentions📖Tau Aggregation Inhibitors — Investment Landscape Analysis40%
mentions📖TGF-beta Signaling Therapeutics for Neurodegeneration: Inves40%
mentions📖Ubiquitin-Proteasome System (UPS) Therapeutics: Investment L40%
mentions📖Wnt Signaling Therapeutics: Investment Landscape Analysis40%
mentions📖[AD](/diseases/alzheimers-disease) Failed Approaches Analysi40%
mentions📖Comprehensive AD Hypothesis Analysis40%
mentions📖ALS Failed Approaches Analysis40%
mentions📖ALS Trial Failure Analysis40%
mentions📖CBS vs PSP: Comparative Mechanism Analysis40%
mentions📖Clinical Trial Success Rate Analysis — Neurodegenerative Dis40%
mentions📖Investment-Evidence Convergence Analysis40%
mentions📖Mechanism of Action Network Convergence Analysis40%
mentions📖MSA-PSP-CBD Comparative Analysis40%
mentions📖PD Failed Approaches Autopsy40%
mentions📖RNA Splicing Dysregulation in 4R-Tauopathies: A Comparative 40%
mentions📖Target Family Consolidation Analysis — Cross-Disease Therape40%
mentions📖Tau Filament Structure in PSP — Cryo-EM Analysis40%
mentions📖Therapeutic Development Failure Mode Analysis Synthesis40%
mentions📖AI-Powered Movement Analysis for Parkinson's Disease40%
mentions📖Failed Alzheimer's Disease Clinical Trials Analysis40%
mentions📖Proteostasis Therapeutics: Investment Landscape Analysis40%
mentions📖Valproic Acid Trial Failure in Progressive Supranuclear Pals40%
related📖BNIP3 Gene40%
related📖GJA140%
related📖GJA1 Protein40%
related📖BNIP3L — BCL2 Interacting Protein 3 Like (NIX)40%
related📖PANX1 Gene40%
related📖PANX1 Protein40%
related📖RAB27A Gene40%
related📖RHOT1 - Mitochondrial Rho GTPase 140%
related📖RHOT1 Protein - MIRO1 - Mitochondrial Rho GTPase 140%